Skip to main content
. 2015 Mar 14;6(12):10350–10365. doi: 10.18632/oncotarget.3585

Table 3. IC50 values for doxorubicin treatment in the presence or absence of salinomycins.

Cell Line NC-Vectors FOXO3a-TM Plasmid
IC50 of Doxa (μg/ml) Combination Index IC50 of Doxb (μg/ml) Combination Index
Dox Dox+Sal Dox Dox+Sal
HuH-7 0.7769 0.5072*** 0.7476 0.6381 0.5065** 0.9372
HepG2 0.1772 0.1283** 0.7243 0.1250 0.1180* 0.9458
SNU-449 2.273 0.5713*** 0.4173 0.4825 0.4117** 0.9962
SNU-387 1.459 0.5063*** 0.5743 0.5811 0.4973*** 1.087
a

IC50 of doxorubicin concentration in two treatments for 48 h for HCC cells with normal expression of FOXO3a

b

IC50 of doxorubicin concentration in two treatments for 48 h for HCC cells with high expression of FOXO3a.

*

p < 0.05

**

p < 0.01

***

p < 0.001.